Please login to the form below

Not currently logged in
Email:
Password:

Cancer therapy deal for Teva and Sinclair

Teva Pharmaceutical and Sinclair IS Pharma are to team up to promote episil, a spray therapy for ongoing supportive cancer care

Teva Pharmaceutical and Sinclair IS Pharma are to team up to promote episil (benzydamine hydrochloride) an oral spray for the treatment of pain in patients undergoing chemotherapy and radiotherapy during cancer treatment.

The licence agreement will see Teva hold exclusive commercialisation rights for episil in Germany, Spain, Poland, Switzerland and the Czech Republic, while Sinclair IS is to retain an option to co-promote the drug in Germany and Spain where it has its own direct sales force.

Financial details of the deal were not disclosed.

Teva said it expects to launch episil in the fourth quarter of 2011.

Chris Spooner, CEO of Sinclair IS, commented that similar agreements were likely for the company in the future. He said: "This is the first in what we expect to be a number of marketing and co-marketing partnerships. episil is a cornerstone of our supportive oncology portfolio and we look forward to working with Teva as we drive sales of this product."

Sinclair IS was formed earlier this year following the merger of Sinclair and IS Pharma.

31st August 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

The other side of … Crohn’s disease
What patients say is their truth about living with chronic conditions. “I want to believe in my doctor but I feel more comfortable getting my guidance elsewhere.”...
OPEN Health brings the Best of Both Worlds to MAPS EMEA 2020
...
1000 Voices Survey
The patient voice is key to creating meaningful changes in healthcare; to drive patients to be more actively involved in their care, which leads to better outcomes. So, we went...

Infographics